Improve Medical Instruments Co., Ltd.

SZSE:300030 Stock Report

Market Cap: CN¥2.0b

Improve Medical Instruments Balance Sheet Health

Financial Health criteria checks 6/6

Improve Medical Instruments has a total shareholder equity of CN¥717.6M and total debt of CN¥381.3M, which brings its debt-to-equity ratio to 53.1%. Its total assets and total liabilities are CN¥1.3B and CN¥613.1M respectively.

Key information

53.1%

Debt to equity ratio

CN¥381.30m

Debt

Interest coverage ration/a
CashCN¥249.83m
EquityCN¥717.60m
Total liabilitiesCN¥613.06m
Total assetsCN¥1.33b

Recent financial health updates

No updates

Recent updates

Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Oct 28
Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Improve Medical Instruments Co., Ltd. (SZSE:300030) Held Back By Insufficient Growth Even After Shares Climb 46%

Sep 10
Improve Medical Instruments Co., Ltd. (SZSE:300030) Held Back By Insufficient Growth Even After Shares Climb 46%

Revenues Working Against Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Share Price Following 26% Dive

Jun 06
Revenues Working Against Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Share Price Following 26% Dive

A Look At The Fair Value Of Improve Medical Instruments Co., Ltd. (SZSE:300030)

Jun 04
A Look At The Fair Value Of Improve Medical Instruments Co., Ltd. (SZSE:300030)

Benign Growth For Improve Medical Instruments Co., Ltd. (SZSE:300030) Underpins Stock's 27% Plummet

Apr 16
Benign Growth For Improve Medical Instruments Co., Ltd. (SZSE:300030) Underpins Stock's 27% Plummet

Improve Medical Instruments Co., Ltd.'s (SZSE:300030) 25% Dip In Price Shows Sentiment Is Matching Revenues

Feb 26
Improve Medical Instruments Co., Ltd.'s (SZSE:300030) 25% Dip In Price Shows Sentiment Is Matching Revenues

Financial Position Analysis

Short Term Liabilities: 300030's short term assets (CN¥619.6M) exceed its short term liabilities (CN¥535.2M).

Long Term Liabilities: 300030's short term assets (CN¥619.6M) exceed its long term liabilities (CN¥77.9M).


Debt to Equity History and Analysis

Debt Level: 300030's net debt to equity ratio (18.3%) is considered satisfactory.

Reducing Debt: 300030's debt to equity ratio has reduced from 56.6% to 53.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable 300030 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: 300030 is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 3.3% per year.


Discover healthy companies